Primer on Tumor Immunology and Biological Therapy of Cancer

October 1, 2010
Hyatt Regency Washington on Capitol Hill
Washington, D.C.

The Primer provides a general overview of immunology as it applies to cancer etiology, biology and therapy. The target audience for this program is basic and clinical investigators from academic, regulatory, and biopharmaceutical venues. The audience includes clinicians, researchers, students, post-doctoral fellows, and allied health professionals.

Topics Addressed (subject to change)

• Adoptive T-Cell Therapy	• Immune Monitoring
• Cancer Vaccines	• Innate Immunity and Inflammation
• Cytokines	• Overview of Adaptive Immunity
• Dendritic Cells	• Regulatory Immune Cells
• Immune Modulating Antibodies	• Tumor Microenvironment

Organizers
Patrick Hwu, MD MD Anderson Cancer Center	Walter J. Urba, MD, PhD Earle A. Chiles Research Institute

View the 2010 iSBTc program supporters.

The Primer on Tumor Immunology and Biological Therapy of Cancer is a non-accredited continuing medical education event. No credits are offered for physician participation in this educational program.